Abstract
Aim: To measure the association between cerebral palsy (CP) and non-CP-related movement difficulties and health-related quality of life (HRQoL) among 5-year-old children born extremely preterm (<28 weeks gestational age). Method: We included 5-year-old children from a multi-country, population-based cohort of children born extremely preterm in 2011 to 2012 in 11 European countries (n = 1021). Children without CP were classified using the Movement Assessment Battery for Children, Second Edition as having significant movement difficulties (≤5th centile of standardized norms) or being at risk of movement difficulties (6th–15th centile). Parents reported on a clinical CP diagnosis and HRQoL using the Pediatric Quality of Life Inventory. Associations were assessed using linear and quantile regressions. Results: Compared to children without movement difficulties, children at risk of movement difficulties, with significant movement difficulties, and CP had lower adjusted HRQoL total scores (β [95% confidence interval] = −5.0 [−7.7 to −2.3], −9.1 [−12.0 to −6.1], and − 26.1 [−31.0 to −21.2]). Quantile regression analyses showed similar decreases in HRQoL for all children with CP, whereas for children with non-CP-related movement difficulties, reductions in HRQoL were more pronounced at lower centiles. Interpretation: CP and non-CP-related movement difficulties were associated with lower HRQoL, even for children with less severe difficulties. Heterogeneous associations for non-CP-related movement difficulties raise questions for research about mitigating and protective factors.
| Original language | English |
|---|---|
| Pages (from-to) | 1617-1628 |
| Number of pages | 12 |
| Journal | Developmental Medicine and Child Neurology |
| Volume | 65 |
| Issue number | 12 |
| Early online date | 14 May 2023 |
| DOIs | |
| Publication status | Published - Dec 2023 |
Bibliographical note
Funding Information:Additional funding is acknowledged from the following regions: France (French Institute of Public Health Research and Institute of Public Health and their partners the French Health Ministry, the National Institute of Health and Medical Research, the National Institute of Cancer, and the National Solidarity Fund for Autonomy, and grant no. ANR‐11‐EQPX‐0038 from the National Research Agency through the French Equipex Program of Investments in the Future and the PremUp Foundation); UK (funding from The Neonatal Survey from Neonatal Networks for the East Midlands and Yorkshire and Humber regions).
Funding Information:
Funding was received from the European Union Seventh Framework Programme (FP7/2007‐2013) under grant agreement no. 259882 and Horizon 2020 Research and Innovation Program under grant agreement nos. 633724 and 733280. Raquel Costa was supported by the FSE and FCT under a postdoctoral grant no. SFRH/BPD/117597/2016. EPIUnit (UIDB/04750/2020) and ITR (LA/P/0064/2020) are financed by the Fundação para a Ciência e a Tecnologia.
Publisher Copyright:
© 2023 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.